These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8211258)

  • 1. An historical and clinical review of the interaction of leprosy and pregnancy: a cycle to be broken.
    Duncan ME
    Soc Sci Med; 1993 Aug; 37(4):457-72. PubMed ID: 8211258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy and leprosy neuropathy.
    Duncan ME
    Indian J Lepr; 1996; 68(1):23-34. PubMed ID: 8727111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leprosy reactions in postelimination stage: the Bangladesh experience.
    Mowla MR; Ara S; Mizanur Rahman AFM; Tripura SP; Paul S
    J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):705-711. PubMed ID: 27859670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil.
    Hungria EM; Oliveira RM; Penna GO; Aderaldo LC; Pontes MA; Cruz R; Gonçalves HS; Penna ML; Kerr LR; Stefani MM; Bührer-Sékula S
    Infect Dis Poverty; 2016 Dec; 5(1):110. PubMed ID: 27919284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M; Berhe D
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy and leprosy: a comprehensive literature review.
    Lockwood DN; Sinha HH
    Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):6-12. PubMed ID: 10407623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal hyperbilirubinemia after treatment of maternal leprosy.
    Thornton YS; Bowe ET
    South Med J; 1989 May; 82(5):668. PubMed ID: 2717998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Initial manifestation of tuberculoid leprosy in pregnancy. Guidelines for diagnosis and therapy].
    Neuer A; Spang E; Sticht-Groh V
    Geburtshilfe Frauenheilkd; 1996 Mar; 56(3):156-60. PubMed ID: 8674964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
    Kar HK; Sharma P
    Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.
    Penna GO; Bührer-Sékula S; Kerr LRS; Stefani MMA; Rodrigues LC; de Araújo MG; Ramos AMC; de Andrade ARC; Costa MB; Rosa PS; Gonçalves HS; Cruz R; Barreto ML; Pontes MAA; Penna MLF
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005725. PubMed ID: 28704363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuritis in pregnancy and lactation.
    Duncan ME; Pearson JM
    Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):31-8. PubMed ID: 6281203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of multidrug therapy in paucibacillary leprosy patients; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):436-44. PubMed ID: 1474282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactional states in multibacillary Hansen disease patients during multidrug therapy.
    Nery JA; Vieira LM; de Matos HJ; Gallo ME; Sarno EN
    Rev Inst Med Trop Sao Paulo; 1998; 40(6):363-70. PubMed ID: 10436656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leprosy reactions: The predictive value of Mycobacterium leprae-specific serology evaluated in a Brazilian cohort of leprosy patients (U-MDT/CT-BR).
    Hungria EM; Bührer-Sékula S; de Oliveira RM; Aderaldo LC; Pontes AA; Cruz R; Gonçalves HS; Penna ML; Penna GO; Stefani MM
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005396. PubMed ID: 28222139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy.
    Jing Z; Zhang R; Zhou D; Chen J
    Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognizing and managing the immunologic reactions in leprosy.
    Kamath S; Vaccaro SA; Rea TH; Ochoa MT
    J Am Acad Dermatol; 2014 Oct; 71(4):795-803. PubMed ID: 24767732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythema leprosum--after treatment of Lepromatous Leprosy.
    Eickelmann M; Steinhoff M; Metze D; Tomimori-Yamashita J; Sunderkötter C
    J Dtsch Dermatol Ges; 2010 Jun; 8(6):450-3. PubMed ID: 19922466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leprosy and AIDS: a review of the literature and speculations on the impact of CD4+ lymphocyte depletion on immunity to Mycobacterium leprae.
    Miller RA
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):639-44. PubMed ID: 1687045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth and development of children of mothers with leprosy and healthy controls.
    Duncan ME; Miko T; Howe R; Hansen S; Menzel S; Melsom R; Frommel D; Bezuneh E; Hunegnaw M; Amare G; Wagaye W; Challis A; Aseffa A
    Ethiop Med J; 2007 Oct; 45 Suppl 1():9-23. PubMed ID: 18710070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.